Fulgent Genetics, Inc.
FLGT
$19.45
-$0.45-2.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -55.77% | -115.32% | -297.72% | 54.89% | -117.65% |
| Total Depreciation and Amortization | 26.79% | 1.37% | -1.29% | 1.99% | -1.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.39% | -16.47% | 27.53% | -51.01% | 125.45% |
| Change in Net Operating Assets | 59.41% | 271.17% | -542.98% | 109.26% | -1,391.17% |
| Cash from Operations | 21.26% | 260.17% | -412.35% | 171.62% | -804.11% |
| Capital Expenditure | 43.48% | -10.26% | -31.82% | 69.03% | 47.27% |
| Sale of Property, Plant, and Equipment | -- | 300.00% | -- | -92.11% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.25% | 120.99% | 168.14% | -25.02% | 197.71% |
| Cash from Investing | -4.87% | -60.55% | 140.63% | 112.40% | 631.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 6.93% | 35.29% | 35.29% | 85.38% |
| Issuance of Common Stock | -- | -- | -98.04% | -- | -- |
| Repurchase of Common Stock | -846.63% | -319.06% | -84.71% | 17.17% | -368.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -818.31% | -301.30% | -63.30% | 21.52% | -130.19% |
| Foreign Exchange rate Adjustments | 2,100.00% | -72.73% | 155.97% | -90.45% | 144.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -85.89% | -320.76% | -2,227.40% | 529.20% | 97.42% |